Food And Drug Administration Approves Brand New Libido-Boosting Drug for Premenopausal Ladies

Food And Drug Administration Approves Brand New Libido-Boosting Drug for Premenopausal Ladies The usa Food and Drug management (Food And Drug Administration) today approved bremelanotide (Vyleesi, AMAG Pharmaceuticals), a first-in-class melanocortin 4 receptor agonist for hypoactive sexual interest disorder (HSDD) in premenopausal ladies. It joins flibanserin (Addyi, Sprout Pharmaceuticals), the only real other HSDD that […]

read more